PF-06471553

N/A

Report date: 2023/09/20 15:19:55
NME

Base Information

Drug NamePF-06471553
Drug Alias NamePF-06471553
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase inhibitors
TargetsBeta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A